Skip to main content

Table 3 WT1 and EVI1 expression levels before and after treatment and their correlation with clinical response are reported

From: Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study

Pt ID

WT1 @ start

WT1 @ end

EVI1 @ start

EVI1 @ end

response

1

high

high

low

low

minor

2

high

high

low

low

stable

3

high

normal

low

low

major

4

high

normal

low

low

stable

5

normal

normal

high

low

minor

6

normal

normal

low

low

minor

7

high

high

high

low

stable

8

high

normal

low

high

major

9

high

high

low

low

stable

10

high

high

N/A

N/A

stable

11

high

high

high

low

stable

12

high

normal

N/A

N/A

major